Artificial Intelligence in MRI Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Intelligence in MRI Market 

5.1. COVID-19 Landscape: Artificial Intelligence in MRI Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Intelligence in MRI Market, By Clinical Applications

8.1. Artificial Intelligence in MRI Market, by Clinical Applications, 2023-2032

8.1.1. Musculoskeletal

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Colon

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Prostate

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. Liver

8.1.4.1. Market Revenue and Forecast (2021-2032)

8.1.5. Cardiovascular

8.1.5.1. Market Revenue and Forecast (2021-2032)

8.1.6. Neurology

8.1.6.1. Market Revenue and Forecast (2021-2032)

8.1.7. Lung

8.1.7.1. Market Revenue and Forecast (2021-2032)

8.1.8. Breast

8.1.8.1. Market Revenue and Forecast (2021-2032)

8.1.9. Others

8.1.9.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Artificial Intelligence in MRI Market, By Offering Type

9.1. Artificial Intelligence in MRI Market, by Offering Type, 2023-2032

9.1.1. Hardware

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Software

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Services

9.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Artificial Intelligence in MRI Market, By Technology 

10.1. Artificial Intelligence in MRI Market, by Technology, 2023-2032

10.1.1. Deep learning

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Machine learning

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Computer vision

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. NLP (Natural Language Processing)

10.1.4.1. Market Revenue and Forecast (2021-2032)

10.1.5. Speech recognition

10.1.5.1. Market Revenue and Forecast (2021-2032)

10.1.5. Querying method

10.1.5.1. Market Revenue and Forecast (2021-2032)

10.1.5. Other

10.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Artificial Intelligence in MRI Market, By Deployment Type

11.1. Artificial Intelligence in MRI Market, by Deployment Type, 2023-2032

11.1.1. On-premise

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Cloud

11.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Artificial Intelligence in MRI Market, By End-User

12.1. Artificial Intelligence in MRI Market, by End-User, 2023-2032

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2021-2032)

12.1.2. Clinics

12.1.2.1. Market Revenue and Forecast (2021-2032)

12.1.3. Research and laboratories

12.1.3.1. Market Revenue and Forecast (2021-2032)

12.1.4. Others

12.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 13. Global Artificial Intelligence in MRI Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.1.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.1.3. Market Revenue and Forecast, by Technology (2021-2032)

13.1.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.1.5. Market Revenue and Forecast, by End-User (2021-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.1.6.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.1.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.1.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.1.6.5. Market Revenue and Forecast, by End-User (2021-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.1.7.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.1.7.3. Market Revenue and Forecast, by Technology (2021-2032)

13.1.7.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.1.7.5. Market Revenue and Forecast, by End-User (2021-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.2.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.2.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.4. Market Revenue and Forecast, by Deployment Type (2021-2032) 

13.2.5. Market Revenue and Forecast, by End-User (2021-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.2.6.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.2.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.7. Market Revenue and Forecast, by Deployment Type (2021-2032) 

13.2.8. Market Revenue and Forecast, by End-User (2021-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.2.9.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.2.9.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.10. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.2.11. Market Revenue and Forecast, by End-User (2021-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.2.12.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.2.12.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.12.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.2.13. Market Revenue and Forecast, by End-User (2021-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.2.14.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.2.14.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.14.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.2.15. Market Revenue and Forecast, by End-User (2021-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.3.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.3.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.3.5. Market Revenue and Forecast, by End-User (2021-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.3.6.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.3.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.3.7. Market Revenue and Forecast, by End-User (2021-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.3.8.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.3.8.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.3.9. Market Revenue and Forecast, by End-User (2021-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.3.10.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.3.10.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.10.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.3.10.5. Market Revenue and Forecast, by End-User (2021-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.3.11.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.3.11.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.11.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.3.11.5. Market Revenue and Forecast, by End-User (2021-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.4.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.4.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.4.5. Market Revenue and Forecast, by End-User (2021-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.4.6.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.4.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.4.7. Market Revenue and Forecast, by End-User (2021-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.4.8.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.4.8.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.4.9. Market Revenue and Forecast, by End-User (2021-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.4.10.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.4.10.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.10.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.4.10.5. Market Revenue and Forecast, by End-User (2021-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.4.11.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.4.11.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.11.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.4.11.5. Market Revenue and Forecast, by End-User (2021-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.5.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.5.3. Market Revenue and Forecast, by Technology (2021-2032)

13.5.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.5.5. Market Revenue and Forecast, by End-User (2021-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.5.6.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.5.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.5.6.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.5.7. Market Revenue and Forecast, by End-User (2021-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Clinical Applications (2021-2032)

13.5.8.2. Market Revenue and Forecast, by Offering Type (2021-2032)

13.5.8.3. Market Revenue and Forecast, by Technology (2021-2032)

13.5.8.4. Market Revenue and Forecast, by Deployment Type (2021-2032)

13.5.8.5. Market Revenue and Forecast, by End-User (2021-2032)

Chapter 14. Company Profiles

14.1. IBM Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Bay Labs Inc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Resonance Health Ltd

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Zebra Medical Vision Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Samsung Electronics Co.Ltd

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Arterys Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Koninklijke Philips N.V.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Nuance Communications Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Siemens Healthneer AG

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. OrCam

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms